According to the HPA, high expression of CAV2, COL11A1, DNAJB4, THY1 and VCAN decreased the 5-year survival for breast, CNS, colon, kidney, lung and ovarian tumors (Fig. 7a). This evidence concerns the gene THY1 and ovarian neoplasm.